Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00225082 · ClinicalTrials.gov registry record
SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial Function
A clinical trial of HIV Infection, sponsored by Northwestern University.
- Completed
- Registry status
- 12
- Enrollment target
- 1
- Study location
NCT00225082 is a study of HIV Infection that has completed, run by Northwestern University. The registered enrollment target is 12 participants, below the 243-participant average among 73 other HIV Infection trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00225082, a study of HIV Infection, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
HIV infected subjects receiving antiretroviral treatment for greater than 6 years with be evaluated for clinical lipoatrophy and mitochondrial function after switching nucleoside analogues from stavudine (d4T) to tenofovir treatment and after 4. Hypothesis: Tenofovir therapy will increase peripheral fat content as assessed by DEXA and mitochondrial function at 48 weeks.
Conditions Studied
Interventions
- DRUG Nucleoside analogue switch
Study Locations (1)
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2004-11 |
| Est. Completion | 2007-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00225082
The ClinicalTrials.gov registry entry for NCT00225082 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 243-participant average among 73 other HIV Infection trials with a reported enrollment target (95% lower). The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with HIV Infection appearing as the primary indexed condition, and to 1 intervention - of which Nucleoside analogue switch is the first listed.
NCT00225082 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT00225082 about?
NCT00225082 is a clinical study titled "SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial Function". HIV infected subjects receiving antiretroviral treatment for greater than 6 years with be evaluated for clinical lipoatrophy and mitochondrial function after switching nucleoside analogues from stavudine (d4T) to tenofovir treatment and after 4. Hypothesis: Tenofovir therapy will increase periphera...
What is the current status of trial NCT00225082?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2004-11. Estimated completion is 2007-10.
What conditions does trial NCT00225082 study?
This clinical trial studies the following conditions: HIV Infection.
What interventions are being tested in trial NCT00225082?
The interventions under investigation include: Nucleoside analogue switch (DRUG).
Who is sponsoring clinical trial NCT00225082?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00225082 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer
RECRUITING · Phase 2
-
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
RECRUITING · Phase 1
-
MAPS PrEP Van Study
RECRUITING · Phase 4
-
HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
RECRUITING · NA
-
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
RECRUITING · NA
-
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.